U.S. pharmaceutical wholesaler McKesson Corp, which last week reached a deal to acquire Germany's Celesio AG, reported on Thursday a 79 percent drop in quarterly net profit as one-time inventory and other charges offset revenue gains. For its full fiscal year ending March 31, McKesson said it expects adjusted earnings per share from continuing operations of $8.05 to $8.20 per share, down from a previous estimate of $8.40 to $8.70 per share, due to higher acquisition and inventory-related charges.For its fiscal third quarter ended Dec. 31, McKesson posted a net profit of $64 million, or 28 cents per share, compared with $298 million, or $1.24 per share, a year earlier.Excluding one-time charges, the company earned $1.45 per share, well short of the $1.84 per share forecast, on average, by analysts, according to Thomson Reuters I/B/E/S.Revenue rose 10 percent to $34.3 billion. Analysts had expected $33.57 billion.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.97% or $0.35/share to $36.29. In the past year, the shares have traded as low as $29.33 and as high as $38.73. On average, 703654 shares of TRI exchange hands on a given day and today's volume is recorded at 415660.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.92% or $0.37/share to $40.56. In the past year, the shares have traded as low as $29.40 and as high as $42.10. On average, 871422 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 486190.
Source
